Haemonetics Corporation (HAE) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 346.35M | 338.97M | 327.31M | 321.39M | 330.6M | 348.54M | 345.51M | 336.17M | 343.29M | 336.25M | 318.18M | 311.33M |
| Revenue Growth % | 4.76% | -2.75% | -5.27% | -4.4% | -3.7% | 3.66% | 8.59% | 7.98% | 12.77% | 10.14% | 6.96% | 19.08% |
| Cost of Goods Sold | 148.14M | 147.56M | 143.89M | 129.53M | 148.68M | 148.63M | 154.31M | 156.88M | 154.35M | 151.32M | 147.62M | 143.86M |
| COGS % of Revenue | 42.77% | 43.53% | 43.96% | 40.3% | 44.97% | 42.64% | 44.66% | 46.67% | 44.96% | 45% | 46.39% | 46.21% |
| Gross Profit | 198.21M | 191.41M | 183.42M | 191.86M | 181.92M | 199.91M | 191.2M | 179.29M | 188.94M | 184.93M | 170.57M | 167.47M |
| Gross Margin % | 57.23% | 56.47% | 56.04% | 59.7% | 55.03% | 57.36% | 55.34% | 53.33% | 55.04% | 55% | 53.61% | 53.79% |
| Gross Profit Growth % | 8.95% | -4.26% | -4.07% | 7.01% | -3.72% | 8.1% | 12.1% | 7.06% | 15.03% | 16.56% | 8.02% | 17.89% |
| Operating Expenses | 146.76M | 121.85M | 116.14M | 137.99M | 130.46M | 140.89M | 139.5M | 139.53M | 159M | 138.95M | 135.26M | 113.81M |
| OpEx % of Revenue | 42.37% | 35.95% | 35.48% | 42.93% | 39.46% | 40.42% | 40.38% | 41.51% | 46.32% | 41.32% | 42.51% | 36.56% |
| Selling, General & Admin | 121.83M | 107.56M | 101.62M | 0 | 114.5M | 0 | 0 | 0 | 115.12M | 0 | 0 | 0 |
| SG&A % of Revenue | 35.17% | 31.73% | 31.05% | - | 34.63% | - | - | - | 33.54% | - | - | - |
| Research & Development | 14.45M | 14.29M | 14.52M | 16.26M | 15.96M | 15.83M | 14.14M | 14.45M | 24.46M | 13.27M | 12.66M | 12.65M |
| R&D % of Revenue | 4.17% | 4.21% | 4.44% | 5.06% | 4.83% | 4.54% | 4.09% | 4.3% | 7.12% | 3.94% | 3.98% | 4.06% |
| Other Operating Expenses | 1000K | 0 | 0 | 1000K | 0 | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Operating Income | 51.45M | 69.56M | 67.28M | 53.87M | 51.46M | 59.03M | 51.7M | 39.76M | 29.94M | 45.98M | 35.3M | 53.66M |
| Operating Margin % | 14.85% | 20.52% | 20.55% | 16.76% | 15.57% | 16.94% | 14.96% | 11.83% | 8.72% | 13.67% | 11.1% | 17.24% |
| Operating Income Growth % | -0.03% | 17.84% | 30.14% | 35.51% | 71.87% | 28.39% | 46.44% | -25.91% | -15.07% | 6.24% | -24.46% | 74.4% |
| EBITDA | 51.45M | 96.94M | 95.53M | 82.63M | 79.67M | 88.05M | 80.91M | 68.89M | 48.98M | 69.51M | 58.46M | 76.55M |
| EBITDA Margin % | 14.85% | 28.6% | 29.19% | 25.71% | 24.1% | 25.26% | 23.42% | 20.49% | 14.27% | 20.67% | 18.37% | 24.59% |
| EBITDA Growth % | -35.43% | 10.1% | 18.07% | 19.94% | 62.66% | 26.68% | 38.42% | -10% | -3.21% | 3.98% | -17.1% | 44.81% |
| D&A (Non-Cash Add-back) | 0 | 27.39M | 28.25M | 28.76M | 28.21M | 29.02M | 29.22M | 29.14M | 19.04M | 23.53M | 23.15M | 22.89M |
| EBIT | 51.45M | 69.56M | 67.28M | 64.94M | 51.46M | 66.11M | 59.76M | 50.98M | 49.4M | 58.99M | 42.62M | 53.65M |
| Net Interest Income | -5.37M | -8.12M | -7.21M | -4.07M | 1.39M | -9.11M | -6.99M | 6.96M | -6.53M | -1.95M | -2.47M | -2.07M |
| Interest Income | 0 | 0 | 0 | 0 | 1.39M | 0 | 0 | 6.96M | 0 | 0 | 0 | 0 |
| Interest Expense | 5.37M | 8.12M | 7.21M | 4.07M | 0 | 9.11M | 6.99M | 0 | 6.53M | 1.95M | 2.47M | 2.07M |
| Other Income/Expense | -79.85M | -9.59M | -15.99M | -8.7M | 19.27M | -9.11M | -6.99M | 6.96M | -6.53M | -1.95M | -2.47M | -2.07M |
| Pretax Income | -28.4M | 59.98M | 51.28M | 45.17M | 70.74M | 49.92M | 44.7M | 46.71M | 23.41M | 44.03M | 32.83M | 51.59M |
| Pretax Margin % | -8.2% | 17.69% | 15.67% | 14.05% | 21.4% | 14.32% | 12.94% | 13.9% | 6.82% | 13.09% | 10.32% | 16.57% |
| Income Tax | -8.25M | 15.23M | 12.6M | 11.14M | 12.76M | 12.42M | 10.87M | 8.34M | 3.05M | 12.79M | 7.92M | 10.55M |
| Effective Tax Rate % | 29.06% | 25.4% | 24.57% | 24.66% | 18.03% | 24.89% | 24.32% | 17.85% | 13.01% | 29.04% | 24.13% | 20.45% |
| Net Income | -20.15M | 44.74M | 38.68M | 34.03M | 57.98M | 37.49M | 33.83M | 38.37M | 20.37M | 31.24M | 24.91M | 41.04M |
| Net Margin % | -5.82% | 13.2% | 11.82% | 10.59% | 17.54% | 10.76% | 9.79% | 11.41% | 5.93% | 9.29% | 7.83% | 13.18% |
| Net Income Growth % | -134.75% | 19.33% | 14.34% | -11.32% | 184.68% | 20.02% | 35.82% | -6.5% | -30.68% | -5.17% | -24.97% | 106.48% |
| Net Income (Continuing) | -20.15M | 44.74M | 38.68M | 34.03M | 57.98M | 37.49M | 33.83M | 38.37M | 20.37M | 31.24M | 24.91M | 41.04M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.44 | 0.95 | 0.81 | 0.70 | 1.17 | 0.74 | 0.66 | 0.74 | 0.40 | 0.61 | 0.48 | 0.80 |
| EPS Growth % | -137.61% | 28.38% | 22.73% | -5.41% | 192.5% | 21.31% | 37.5% | -7.5% | -29.82% | -4.69% | -25% | 110.53% |
| EPS (Basic) | -0.44 | 0.96 | 0.81 | 0.71 | 1.17 | 0.75 | 0.66 | 0.75 | 0.40 | 0.62 | 0.49 | 0.81 |
| Diluted Shares Outstanding | 46.22M | 46.99M | 47.66M | 48.35M | 49.48M | 50.64M | 51.24M | 51.56M | 51.41M | 51.45M | 51.4M | 51.34M |
| Basic Shares Outstanding | 46.22M | 46.79M | 47.59M | 48.11M | 49.19M | 50.29M | 50.9M | 50.94M | 50.79M | 50.77M | 50.73M | 50.54M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |